As on Thursday, Acumen Pharmaceuticals Inc (NASDAQ: ABOS) started slowly as it slid -6.53% to $1.86, before settling in for the price of $1.99 at the close. Taking a more long-term approach, ABOS posted a 52-week range of $0.86-$2.46.
It was noted that the giant of the Healthcare sector posted annual sales growth of -54.87% over the last 5 years. Meanwhile, its Annual Earning per share during the time was -54.87%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -19.63%. This publicly-traded company’s shares outstanding now amounts to $60.57 million, simultaneously with a float of $47.79 million. The organization now has a market capitalization sitting at $112.67 million. At the time of writing, stock’s 50-day Moving Average stood at $1.9615, while the 200-day Moving Average is $1.4892.
Acumen Pharmaceuticals Inc (ABOS) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. Acumen Pharmaceuticals Inc’s current insider ownership accounts for 21.11%, in contrast to 51.02% institutional ownership.
Acumen Pharmaceuticals Inc (ABOS) Earnings and Revenue Records
Acumen Pharmaceuticals Inc’s EPS decrease for this current 12-month fiscal period is -19.63% and is forecasted to reach -1.58 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 7.37% through the next 5 years, which can be compared against the -54.87% growth it accomplished over the previous five years trading on the market.
Acumen Pharmaceuticals Inc (NASDAQ: ABOS) Trading Performance Indicators
Let’s observe the current performance indicators for Acumen Pharmaceuticals Inc (ABOS). It’s Quick Ratio in the last reported quarter now stands at 6.02.
In the same vein, ABOS’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -2.21, a figure that is expected to reach -0.45 in the next quarter, and analysts are predicting that it will be -1.58 at the market close of one year from today.
Technical Analysis of Acumen Pharmaceuticals Inc (ABOS)
Through scrutinizing the latest numbers posted by the [Acumen Pharmaceuticals Inc, ABOS], it can be observed that its last 5-days Average volume of 0.26 million was better the volume of 0.26 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 25.73% While, its Average True Range was 36.41.
Raw Stochastic average of Acumen Pharmaceuticals Inc (ABOS) in the period of the previous 100 days is set at 52.00%, which indicates a major rise in contrast to 20.90% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.1485 that was higher than 0.1476 volatility it exhibited in the past 100-days period.
